NEUROCRINE BIOSCIENCES INC Insider Trading for November 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEUROCRINE BIOSCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEUROCRINE BIOSCIENCES INC for November 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 27 2018 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Sell | S | 91.37 | 4,124 | 376,790 | 29,512 | 33.6 K to 29.5 K (-12.26 %) |
| Nov 13 2018 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Sell | S | 103.30 | 4,123 | 425,893 | 33,636 | 37.8 K to 33.6 K (-10.92 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 8.66 | 15,046 | 130,298 | 54,048 | |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 5.76 | 9,122 | 52,543 | 9,121 | |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 35.99 | 5,231 | 188,264 | 31,533 | |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 35.99 | 9,420 | 339,026 | 36,764 | |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 110.26 | 15,046 | 1,659,014 | 135,997 | 151 K to 136 K (-9.96 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 8.66 | 15,046 | 130,298 | 151,043 | 136 K to 151 K (+11.06 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 110.03 | 9,122 | 1,003,708 | 135,997 | 145.1 K to 136 K (-6.29 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 5.76 | 9,122 | 52,543 | 145,119 | 136 K to 145.1 K (+6.71 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 110.00 | 5,231 | 575,410 | 135,997 | 141.2 K to 136 K (-3.70 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 35.99 | 5,231 | 188,264 | 141,228 | 136 K to 141.2 K (+3.85 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 110.10 | 9,420 | 1,037,167 | 135,997 | 145.4 K to 136 K (-6.48 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 35.99 | 9,420 | 339,026 | 145,417 | 136 K to 145.4 K (+6.93 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lloyd-Smith Malcolm | Chief Regulatory Of ... | Option Exercise | M | 15.45 | 3,300 | 50,985 | 9,956 | |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lloyd-Smith Malcolm | Chief Regulatory Of ... | Option Exercise | M | 15.45 | 5,700 | 88,065 | 13,256 | |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lloyd-Smith Malcolm | Chief Regulatory Of ... | Sell | S | 110.00 | 3,300 | 363,000 | 15,318 | 18.6 K to 15.3 K (-17.72 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lloyd-Smith Malcolm | Chief Regulatory Of ... | Buy | M | 15.45 | 3,300 | 50,985 | 18,618 | 15.3 K to 18.6 K (+21.54 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lloyd-Smith Malcolm | Chief Regulatory Of ... | Sell | S | 110.02 | 5,700 | 627,096 | 15,318 | 21 K to 15.3 K (-27.12 %) |
| Nov 08 2018 | NBIX | NEUROCRINE BIOSCIE ... | Lloyd-Smith Malcolm | Chief Regulatory Of ... | Buy | M | 15.45 | 5,700 | 88,065 | 21,018 | 15.3 K to 21 K (+37.21 %) |
| Nov 05 2018 | NBIX | NEUROCRINE BIOSCIE ... | LYONS GARY A | Director | Sell | S | 114.41 | 15,000 | 1,716,213 | 245,697 | 260.7 K to 245.7 K (-5.75 %) |